PURE Global CEO on AI & Data Analytics Revolutionizing Markets
In an interview with TechNews180, Pure Global CEO Phyllis Meng discusses how AI and data analytics are revolutionizing market access and regulatory compliance for MedTech companies. Meng highlights Pure Global's platform, which provides seamless access to global registration data and clinical trial information, eliminating manual searches.
Pure Global's tracking of regulatory trends in over 100 countries offers clients strategic insights and helps them navigate complex multi-regional compliance. With local entities and expert representatives worldwide, Pure Global provides globally informed and locally applicable services, ensuring smooth operations and compliance in each jurisdiction. Looking ahead, Meng sees AI as a crucial technology for future market access and regulatory compliance services.
Read full article here.
Device Type · Jul 20, 2026Aesthetic Devices Regulation: FDA, EU MDR & Global GuideDevice Type · Jul 20, 2026Cardiovascular Devices Regulation: FDA, EU MDR & GlobalBlog · Aug 17, 2026Coronary Stents: Eight Highest-Tier FilesBlog · Aug 10, 2026Surgical Robots: Eight Markets, Eight Regulatory FilesBlog · Aug 3, 2026ISO 10993-1:2025: One Core, Seven Regulatory SystemsBlog · Jul 27, 2026IVD Global Market Access 2026Video · Dec 30, 2025Pure Global’s Year in Review 2025Video · Jul 25, 2025Global Expansion Strategies for Medical Device Manufacturers: How to Align Commercial Growth with Regulatory SuccessLet's Talk,
Anywhere You Are.
Whether looking for more information or ready to partner with us, we're here to guide you through every step of the regulatory process.
Contact us